Bank of America
SCPS

Bank of America’s Scopus BioPharma Inc. Common Stock SCPS Stock Holding History

Bank of America’s Portfolio SCPS Stock Details SCPS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1
Closed – – 8560
2021
Q2 		$0 Sell
1
-10,759
-100% -$76.6K ﹤0.01% 8293
2021
Q1 		$91K Buy
+10,760
New +$113K ﹤0.01% 6430

Other funds holding SCPS

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CLOS
Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America's SCPS Position: Q3 2021 in Review

Bank of America sold out of Scopus BioPharma Inc. Common Stock (SCPS) in Q3 2021, closing a stake of 1 share.

Bank of America first reported a position in SCPS in Q1 2021 and held it in 2 quarters. The position peaked at $91K in Q1 2021. 14 funds tracked by Wall St. Rank hold SCPS as of Q3 2021.

  • Bank of America reported no remaining Scopus BioPharma Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Bank of America sold 1 Scopus BioPharma Inc. Common Stock share in Q3 2021.
  • Bank of America first reported a position in Scopus BioPharma Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Bank of America's Scopus BioPharma Inc. Common Stock position peaked at $91K in Q1 2021.
  • 14 funds tracked by Wall St. Rank held Scopus BioPharma Inc. Common Stock as of Q3 2021.

Based on Bank of America's 13F filing for Q3 2021, filed 15 Nov 2021.